Abstract
For evaluation of specificity and sensitivity of flowcytometric determination of HLA‐B27 antigen, we determined the HLA‐B27 on lymphocytes using HLA‐B27 monoclonal antibody by flow cytometer. Data were compared to those by conventional Terasaki microlymphocytoxicity test and DNA genotyping Polymerase Chain Reaction (PCR) method. One hundred and ninety four patients with various forms of arthritis were included in this study. Forty one of them were HLA‐B27 positive, confirmed by three methods concomitantly with complete accordance. None of serological B27 negative, B7 CREG positive cells were found to be flowcytometric fluorescence positive. Furthermore, there was no significant difference of B27 intensity between different B27 DNA subtypes, nor was there any difference between primary ankylosing spondylitis (AS) and other secondary spondylitis patients as measured by mean channel of fluorescence. It is suggested that flowcytometric measurement of HLA‐B27 antigen is a rapid and reliable method for HLA‐B27 determination. J. Clin. Lab. Anal. 11:369–373, 1997. © 1997 Wiley‐Liss, Inc.
Keywords: flow cytometry, polymerase chain reaction, microlymphocytoxicity, ankylosing spondylitis, HLA‐B27
References
- 1. Schlosstein L, Terasaki PI, Bluestone R, Pearson CM: High association of an HLA antigen, W27, with ankylosing spondylitis. N Eng J Med 288: 704–6, 1973. [DOI] [PubMed] [Google Scholar]
- 2. Brewerton DA, Caffrey M, Hart FD, James DCO, Nicholls A, Sturrock RD: Ankylosing spondylitis and HLA‐B27. Lancet I: 904–907, 1973. [DOI] [PubMed] [Google Scholar]
- 3. Schlosstein T, Teraski PI, Bluestone R, Pearson CM: High association of HLA antigen, w27, with ankylosing spondylitis. N Engl J Med 288: 704–706, 1973. [DOI] [PubMed] [Google Scholar]
- 4. Terasaki PI and McLelland JD: Microdroplet assay of human serum cytotoxins. Nature 204: 998, 1964. [DOI] [PubMed] [Google Scholar]
- 5. Pouletty P, Chang C, Kalil J: Typing of serum soluble HLA‐B27 antigen by ELISA. Tissue Antigen 42: 14–19, 1993. [DOI] [PubMed] [Google Scholar]
- 6. Saiki PK, Mullis KB and Erlich HA: Primer directed enzymatic amplification of DNA with a thermostable DNA polymerase. Science 239: 489–491, 1988. [DOI] [PubMed] [Google Scholar]
- 7. Dominguez O, Coto E, Martmez‐Naves E, Choo SR, Lopez‐Larrea C: Molecular typing of HLA‐B27 alleles. Immunogenetics 36: 277–282, 1992. [DOI] [PubMed] [Google Scholar]
- 8. Olerup O: HLA‐B27 typing by a group‐specific PCR amplification. Tissue Antigens. 43: 253–256, 1994. [DOI] [PubMed] [Google Scholar]
- 9. Albrecht J and Muler HAG: HLA‐B27 typing by use of flow cytofluorometry. Clin Hem 33: 1619–1623, 1987. [PubMed] [Google Scholar]
- 10. Klippel JH, Dieppe PA: Rheumatology In Ankylosing spondylitis: prevalence and demography, Jan Tore Gram, Gunnar Husby, 2nd eds. Mosby‐Year Book Europe Limited, 1994, p 24.1–24.6. [Google Scholar]
- 11. Granfors K, Jalkanen S, Von Essen R: Yersinia antigens in synovial fluid cells from patients with reactive arthritis. N Engl J Med 320: 216–221, 1989. [DOI] [PubMed] [Google Scholar]
- 12. Keat A, Thomas B, Dixey J, Osborn M, Sonnex C, Taylor‐Ribinson D: Chlamydia trachomatis and reactive arthritis—the missing link. Lancet I: 72–74, 1987. [DOI] [PubMed] [Google Scholar]
- 13. Higgins CM, Lund T, Shipley ME, Ebringer A, Sadowska Wroblewska M, Craig RK: Ankylosing spondylitis and HLA‐B27: restriction fragment length polymorphism and sequencing of an HLA‐B27 allele from a patient with ankylosing spondylitis. Ann Rheum Dis 51: 855–862, 1992. [DOI] [PMC free article] [PubMed] [Google Scholar]